Vaccine targeting pancreatic cancer shows promise in new study of clinical trial
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
Business Wire5d
Celerion Expands UK Phase 1 Clinical Research Operations With New Agreement to Relocate to Queen’s University Belfast’s iREACH Health – Clinical Research Innovation Center
LINCOLN, Neb.--(BUSINESS WIRE)--Celerion, a global leader in early clinical research, proudly announces a new agreement to relocate its U.K. Phase 1 clinical research operations to iREACH Health.
Bantam Pharmaceutical Announces Activation of First Phase 1 Clinical Trial Site at MD Anderson Cancer Center
Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in ...
Enrollment Initiated for Phase 2 Clinical trial in Early Alzheimer’s with Sinaptica’s Second-Generation Precision Neuromodulation System
Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation ...
Septerna Announces Discontinuation of SEP-786 Phase 1 Clinical Trial and Plans to Advance Next-Generation Oral Small Molecule PTH1R Agonist
Trial decision follows unanticipated events of elevated unconjugated bilirubin levelsCompany advancing multiple next-generation PTH1R agonists ...
Pharmaceutical Technology4d
Can innovation in clinical trial delivery meet the demands of increasing complexity in drug development?
Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...
How Can Clinical Trials Improve Diversity? CTM’s Cara Brant Explains
Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...
Food Allergy Research & Education3d
Food Allergy Nonprofit, FARE Announces ATANIS Biotech AG as the Winner of Phase 2 of its Innovation Award Diagnostic Challenge
The FARE Innovation Award Diagnostic Challenge is made possible through generous support from the Naddisy Foundation, the ...
manilatimes4d
IMUNON Announces Translational Data from Phase 1/2 OVATION 2 Study of IMNN-001 in Advanced Ovarian Cancer
Data reinforce dose-dependent mechanism with IMNN-001 100mg/m 2 dose associated with 20% increase in IL-12 levels compared to 79mg/m 2 dose. Results from OVATION 2 Study continue ...
If this biotech CEO succeeds millions of cancer patients could benefit
If this CEO succeeds N-Power could save millions of dollars and lives in the fight against cancer. "The impact for cancer ...
Yahoo Finance5d
US Clinical Trials Market Set for Strong Growth by 2029, Driven by Technological Advances and Rising Demand for Personalized Medicine
The US clinical trials market is extensively segmented by different phases of clinical research, service types, indications, and geographical landscapes. The segmentation is indicative of a ...